M

Metacrine, Inc.

14 employees

Metacrine is a clinical-stage bio pharmaceutical company focused on building an innovative pipeline of best-in-class drugs.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Medical
Pharmaceutical

Date founded

2014

Funding rounds raised

Total raised

$65M

from 12 investors over 12 rounds

M

Metacrine, Inc. raised $50M on September 18, 2019

Investors: K2 HealthVentures

M

Metacrine, Inc. raised $65M on June 6, 2018

Investors: Lilly Asia Ventures, LifeSci Venture Partners, Polaris Partners, Vivo Capital, The Invus Group and venBio Partners

M

Metacrine, Inc. raised $22M on December 7, 2017

Investors: venBio Partners and Polaris Partners

M

Metacrine, Inc. raised $36M on August 5, 2015

Investors: ARCH Venture Partners, venBio Partners and Polaris Partners

FAQ